ArticleEuropean urology2023

Re: Population-based Randomized Trial of Screening for Clinically Significant Prostate Cancer ProScreen: A Pilot Study.

Muhieddine Labban et al.PubMed ↗Publisher ↗

No numbers read from the abstract.